BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31678800)

  • 1. Dosimetric comparison and biological evaluation of PET- and CT-based target delineation for LA-NSCLC using auto-planning.
    Shao Y; Wang H; Chen H; Gu H; Duan Y; Feng A; Li X; Xu Z
    Phys Med; 2019 Nov; 67():77-84. PubMed ID: 31678800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of additional use of contrast-enhanced (18)F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer.
    Li XX; Liu NB; Zhu L; Yuan XK; Yang CW; Ren P; Gong LL; Zhao LJ; Xu WG; Wang P
    Br J Radiol; 2015 Jul; 88(1051):20140590. PubMed ID: 25939819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of PET-CT in target volume delineation for three-dimensional conformal radiotherapy in patients with non-small cell lung cancer and atelectasis.
    Yin LJ; Yu XB; Ren YG; Gu GH; Ding TG; Lu Z
    Multidiscip Respir Med; 2013 Mar; 8(1):21. PubMed ID: 23506629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of computed tomography and [18F] fluorodeoxyglucose positron emission tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation.
    Ceresoli GL; Cattaneo GM; Castellone P; Rizzos G; Landoni C; Gregorc V; Calandrino R; Villa E; Messa C; Santoro A; Fazio F
    Tumori; 2007; 93(1):88-96. PubMed ID: 17455878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotoxic investigation of
    Shao Y; Chen H; Wang H; Feng A; Huang Y; Kong Q; Xu Z
    Int J Radiat Biol; 2021; 97(12):1641-1648. PubMed ID: 34597214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515.
    Bradley J; Bae K; Choi N; Forster K; Siegel BA; Brunetti J; Purdy J; Faria S; Vu T; Thorstad W; Choy H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):435-41.e1. PubMed ID: 21075551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
    Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
    PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of computed tomography- and positron emission tomography-based radiotherapy planning in cholangiocarcinoma.
    Onal C; Topuk S; Yapar AF; Yavuz M; Topkan E; Yavuz A
    Onkologie; 2013; 36(9):484-90. PubMed ID: 24051924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
    Vinod SK; Kumar S; Holloway LC; Shafiq J
    J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma.
    Vees H; Casanova N; Zilli T; Imperiano H; Ratib O; Popowski Y; Wang H; Zaidi H; Miralbell R
    Radiat Oncol; 2012 Oct; 7():176. PubMed ID: 23088346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
    Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
    Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric study of a respiratory gating technique based on four-dimensional computed tomography in non-small-cell lung cancer.
    Lin H; Lu H; Shu L; Huang H; Chen H; Chen J; Cheng J; Pang Q; Peng L; Gu J; Lu Z
    J Radiat Res; 2014 May; 55(3):583-8. PubMed ID: 24453355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined PET/CT for IMRT treatment planning of NSCLC: contrast-enhanced CT images for Monte Carlo dose calculation.
    Mönnich D; Lächelt S; Beyer T; Werner MK; Thorwarth D
    Phys Med; 2013 Nov; 29(6):644-9. PubMed ID: 22975430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.
    Wang B; Wang DQ; Lin MS; Lu SP; Zhang J; Chen L; Li QW; Cheng ZK; Liu FJ; Guo JY; Liu H; Qiu B
    BMC Cancer; 2020 Nov; 20(1):1112. PubMed ID: 33198676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).
    Erdi YE; Rosenzweig K; Erdi AK; Macapinlac HA; Hu YC; Braban LE; Humm JL; Squire OD; Chui CS; Larson SM; Yorke ED
    Radiother Oncol; 2002 Jan; 62(1):51-60. PubMed ID: 11830312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning.
    Siva S; Devereux T; Ball DL; MacManus MP; Hardcastle N; Kron T; Bressel M; Foroudi F; Plumridge N; Steinfort D; Shaw M; Callahan J; Hicks RJ; Hofman MS
    Technol Cancer Res Treat; 2016 Feb; 15(1):114-21. PubMed ID: 25575575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric comparison between helical tomotherapy and intensity-modulated radiation therapy plans for non-small cell lung cancer.
    Meng LL; Feng LC; Wang YL; Dai XK; Xie CB
    Chin Med J (Engl); 2011 Jun; 124(11):1667-71. PubMed ID: 21740774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.